Table 1 Characteristics of the sample sets

Number

30

30

30

30

30

30

Age (year)

0.94

0.21

0.24

Waist circumference (cm)

0.12

0.15

0.71

BMI (kg/cm2)

0.27

0.28

0.92

eGFR (mL/min/1.73 m²)

0.0054

0.047

0.50

Hypertension (%)

17.24

16.67

26.67

0.95

0.38

0.35

Type 2 diabetes (%)

13.33

6.67

6.9

0.39

0.41

0.97

Statin use (%)

13.33

13.33

30.00

0.96

0.20

0.22

Fibrate use (%)

_

_

3.33

_

_

_

Tophi (%)

_

_

53.33

_

_

_

Allopurinol use (%)

_

_

68.97

_

_

_

Probenecid usage (%)

_

_

7.41

_

_

_

Fruit consumption (pieces per day)

2.62 ± 1.37

1.88 ± 1.46

1.23 ± 0.96

0.051

<0.00001

0.049

Sugary drink consumption (drinks per day)

2.41 ± 2.40

2.06 ± 1.91

2.78 ± 2.07

0.54

0.53

0.17

Alcohol consumption (drinks/week)

2.40 ± 6.02

4.23 ± 7.95

8.87 ± 13.53

0.32

0.020

0.11

Serum urate (mmol/L)¹

0.346 ± 0.040

0.474 ± 0.063

0.469 ± 0.107

<0.00001

<0.00001

0.84

Number

30

30

30

Age (year)

57.67 ± 12.01

63.17 ± 13.61

53.60 ± 9.11

0.10

0.14

0.0022

Waist circumference (cm)

92.25 ± 15.08

99.38 ± 13.53

107.79 ± 9.92

0.090

<0.00001

0.0096

BMI (kg/cm2)

25.73 ± 6.53

28.85 ± 6.88

31.27 ± 4.18

0.12

0.0001

0.11

eGFR (mL/min/1.73 m²)

80.18 ± 12.49

65.91 ± 16.25

68.86 ± 17.47

0.0004

0.0059

0.50

Hypertension (%)

23.33

36.67

46.67

0.26

0.058

0.43

Type 2 diabetes (%)

3.45

6.9

3.33

0.55

0.98

0.53

Statin use (%)

20.00

23.33

16.67

0.75

0.74

0.52

Fibrate use (%)

_

_

3.33

Tophi (%)

_

_

13.79

Allopurinol use (%)

_

_

75.86

Probenecid usage (%)

_

_

3.7

Fruit consumption (pieces per day)

1.68 ± 1.09

2.27 ± 1.62

2.00 ± 1.39

0.11

0.33

0.50

Sugary drink consumption (drinks per day)

0.77 ± 1.27

1.42 ± 1.77

0.69 ± 1.04

0.11

0.79

0.060

Alcohol consumption (drinks/week)

5.40 ± 6.13

8.68 ± 14.72

6.53 ± 6.06

0.26

0.47

0.46

Serum urate (mmol/L)

0.321 ± 0.046

0.459 ± 0.041

0.403 ± 0.094

<0.00001

0.0001

0.0042